期刊文献+

晚期内皮祖细胞大量扩增方法

Method of expansion of late endothelial progenitor cells
原文传递
导出
摘要 目的通过实验验证一个体外大量扩增晚期内皮祖细胞(EPC)的方法。方法先预铺经辐射后的滋养层细胞(晚期EPC或脐带脐静脉内皮细胞),而后植入分离的人外周血单个核细胞,计数并对比培养21d后获得的晚期EPC克隆数目,并检测目的细胞免疫表型,应用基质胶(matrigel)鉴定其体外管状结构形成能力。结果21d时在预铺的两种滋养层细胞培养条件下获得的晚期EPC克隆数目均比无滋养层细胞的培养方法高20倍(40.0±3.9、39.3±3.1比2.0±1.3,均P〈0.05);且细胞克隆出现的早。目的细胞表达CD31、CD34、内皮型一氧化氮合酶(eNOS)、血管内皮细胞生长因子受体Fit-1、CDl46的2个表型(P1H12、Sendo)、血管内皮钙黏蛋白(VEcadherin)、CDll7,且具有能在体外与matrigel形成管状结构的功能。结论通过提供滋养层细胞的方法可以大量扩增晚期EPC,提示微环境在晚期EPC扩增中起重要作用。 Objective To validate a novel method of expanding late endothelial progenitor cells (EPC) in vitro. Methods We cultured mononuclear cells ( MNC ) from human peripheral blood on the plate with the feeder layer cells, i.e. irradiated late EPC or human umbilical vein endothelial cells. After 21 days, the numbers of late EPC colonies were counted separately. And the surface antigen of late EPC was detected by fluorescence-activated cell sorter (FACS) and their in vitro ability of forming vascular structure examined by matrigel. Results Both colony numbers of late EPC with feeder layer cell culturing were over 20 times than those without (40. 0 +3. 9,39. 3 +3.1 vs 2. 0 -+ 1.3 ,both P 〈0. 05). And the former's late EPC colony appeared earlier. The late EPC expressed CD31, CD34, eNOS, Flt-1, P1H12, Sendo, VE eadherin and CDll7. And vascular structures were discerned. Conclusions The method of feeder layer cells may vastly expand the quantity of late EPC. And microenvironment plays an important role expansion.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第36期2574-2577,共4页 National Medical Journal of China
基金 国家人事部留学人员择优资助项目
关键词 干细胞 细胞增殖 晚期内皮祖细胞 滋养层细胞 Stem cells Cell proliferation Late endothelial progenitor cell Feeder layer cell
  • 相关文献

参考文献11

  • 1Asahara T,Murohara T,Sullivan A,et al. Isolation of putativeprogenitor endothelial cells for angiogenesis. Science, 1997,275 :964-967.
  • 2Kalka C, Masuda H, Takahashi T, et al. Transplantation of exvivo expanded endothelial progenitor cells for therapeuticneovascularization. Proc Natl Acad Sci U S A, 2000,97 : 3422-3427.
  • 3Tateishi-Yuyama E, Matsubara H, Murohara T,et al. Therapeuticangiogenesis for patients with limb ischaemia by autologoustransplantation of bone-marrow cells : a pilot study and arandomised controlled trial. Lancet, 2002,360 : 427-435.
  • 4Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularizationof ischemic myocardium by human bone-marrow-derivedangioblasts prevents cardiomyocyte apoptosis, reduces remodelingand improves cardiac function. Nat Med,2001,7: 430-436.
  • 5Assmus B, Schachinger V, Teupe C, et al. Transplantation ofProgenitor Cells and Regeneration Enhancement in AcuteMyocardial Infarction (TOPCARE-AMI). Circulation, 2002,106 :3009-3017.
  • 6Hur J, Yoon CH, Kim HS,et al. Characterization of two types ofendothelial progenitor cells and their different contributions toneovasculogenesis. Arterioscler Thromb Vase Biol, 2004,24 : 288-293.
  • 7胡允兆,董吁钢,翟玉锋,卢剑华,吴焱贤,周艺,何宗云.辛伐他汀对同型半胱氨酸诱导的人脐静脉内皮细胞的毒性和炎症反应的影响[J].中华医学杂志,2006,86(32):2297-2300. 被引量:3
  • 8Thaloor D,Singh AK,Sidhu GS,et al . Inhibition of angiogenicdifferentiation of human umbilical vein endothelial cells bycurcumin. Cell Growth Diff,1998, 9: 305-312.
  • 9Schofield R. The relationship between the spleen colony-formingcell and the haematopoietic stem cell. Blood Cells, 1978, 4:7-25.
  • 10Ding L, Saunders TL, Enikolopov G, et al. Endothelial andperivascular cells maintain haematopoietic stem cells. Nature,2012,481:457-462..

二级参考文献11

  • 1Clarke R,Daly L,Robinson K,et al.Hyperhomocysteinemia:an independent risk factor for vascular disease.N Engl J Med,1991,324:1149-1155.
  • 2Mayer EL,Jacobsen DW,Robinson K.Homocysteine and coronary atherosclerosis.JACC,1996,27:517-527.
  • 3Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s.Nature,1993,362:801-809.
  • 4Blundell G,Jones BG,Rose FA,et al.Homocysteine mediated endothelial cell toxicity and its amelioration.Atherosclerosis,1996,122:163-172.
  • 5Bickel C,Rupprecht Hj,Blankenberg S.Influence of HMG-CoA reductase inhibitors on markers of coagulation,systemic inflammation and soluble cell adhesion.Int J Cardiol,2002,82:25-31.
  • 6Rosenson RS,Tangney CC,Casey LC.Inhibition of proinflammatory cytokine production by pravastatin.Lancet,1999,353:983-984.
  • 7Knapp AC,Huang J,Starling G.,et al.Inhibitors of HMG-CoA reductor sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.Atherosclerosis,2000,152:217-227.
  • 8Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastation in men with hypercholesterolemia.N Engl J Med,1995,333:1301-1307.
  • 9Corsini A,Raiteri M,Soma MR,et al.Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutary coenzyme A reductase inhibitors.Am J Cardiol,1995,76:21A-28A.
  • 10Lentz SR,Piegors DJ,Malinow MR,et al.Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunctionin monkeys.Circulation,2001,103:1006-1011.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部